Cathepsin B activates human trypsinogen 1 but not proelastase 2 or procarboxypeptidase B

Pancreatology

Volumn 6, Issue 3, 2006, Pages 224-231

  Lindkvist, Björn ^a   Fajardo, Ignacio ^b   Pejler, Gunnar ^b   Borgström, Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Acute pancreatitis; Cathepsin B; Procarboxypeptidase B; Proelastase; Trypsinogen; Tryptase

Indexed keywords

CATHEPSIN B; ELASTASE; ENTEROPEPTIDASE; ENZYME PRECURSOR; PROCARBOXYPEPTIDASE B; PROELASTASE 2; TRYPSIN; TRYPSINOGEN; TRYPSINOGEN ACTIVATION PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; PANCREAS JUICE; PANCREATITIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 33746355218     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000091961     Document Type: Article

References (25)

1. Figarella C, Miszczuk-Jamska B, Barrett AJ: Possible lysosomal activation of pancreatic zymogens. Activation of both human trypsinogens by cathepsin B and spontaneous acid. Activation of human trypsinogen 1. Biol Chem Hoppe Seyler 1988;369(suppl):293-298.
2. Greenbaum LM, Hirshkowitz A, Shoichet I: The activation of trypsinogen by cathepsin B. J Biol Chem 1959;234:2885-2890.
3. Watanabe O, Baccino FM, Steer ML, Meldolesi J: Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol 1984;246:G457-G467.
4. Saluja A, Hashimoto S, Saluja M, Powers RE, Meldolesi J, Steer ML: Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis. Am J Physiol 1987;253:G508-G516.
5. Saluja AK, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbauer B, Steer ML: Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 1997;113:304-310.
6. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, et al: Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000;106:773-781.
7. Kukor Z, Mayerle J, Kruger B, Toth M, Steed PM, Halangk W, et al: Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem 2002;277:21389-21396.
8. Halangk W, Kruger B, Ruthenburger M, Sturzebecher J, Albrecht E, Lippert H, et al: Trypsin activity is not involved in premature, intra-pancreatic trypsinogen activation. Am J Physiol Gastrointest Liver Physiol 2002;282:G367-G374.
9. Hakansson HO, Borgstrom A, Ohlsson K: Porcine pancreatic cationic pro-elastase. Studies on the activation, turnover and interaction with plasma proteinase inhibitors. Biol Chem Hoppe Seyler 1991;372:465-472.
10. Hartwig W, Jimenez RE, Werner J, Lewandrowski KB, Warshaw AL, Fernandez-del Castillo C: Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats. Gastroenterology 1999;117:717-725.
11. Hollender LF, Lehnert P, Wanke M: Acute Pancreatitis. Baltimore, Urban & Schwarzenberg, 1983.
12. Dib M, Zhao X, Wang XD, Andersson R: Role of mast cells in the development of pancreatitis-induced multiple organ dysfunction. Br J Surg 2002;89:172-178.
13. Braganza JM: Towards a novel treatment strategy for acute pancreatitis. 1. Reappraisal of the evidence on aetiogenesis. Digestion 2001;63:69-91.
14. Schwartz LB, Bradford TR: Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 1986;261:7372-7379.
15. Pereira PJ, Bergner A, Macedo-Ribeiro S, Huber R, Matschiner G, Fritz H, et al: Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 1998;392:306-311.
16. Fajardo I, Pejler G: Formation of active monomers from tetrameric human beta-tryptase. Biochem J 2003;369:603-610.
17. Barrett AJ: A new assay for cathepsin B1 and other thiol proteinases. Anal Biochem 1972;47:280-293.
18. Appelros S, Thim L, Borgstrom A: Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998;42:97-102.
19. Ohlsson K, Olsson AS: Purification and partial characterization of human pancreatic elastase. Hoppe Seylers Z Physiol Chem 1976;357:1153-1161.
20. Muller CA, Appelros S, Uhl W, Buchler MW, Borgstrom A: Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002;51:229-235.
21. Petersson U, Borgstrom A: Characterisation of immunoreactive trypsinogen activation peptide (TAP) in urine in acute pancreatitis. Pancreatology 2002;2:290.
22. Szilagyi L, Kenesi E, Katona G, Kaslik G, Juhasz G, Graf L: Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem 2001;276:24574-24580.
23. Teich N, Bodeker H, Keim V: Cathepsin B cleavage of the trypsinogen activation peptide. BMC Gastroenterol 2002;2:16.
24. Braganza JM: Mast cell: pivotal player in lethal acute pancreatitis. QJM 2000;93:469-476.
25. Braganza JM: Towards a novel treatment strategy for acute pancreatitis. 2. Principles and potential practice. Digestion 2001;63:143-162.